drugset / Trial / NCT01566149

Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)

NCT01566149

Phase 3 Completed 49 enrolled Organon and Co
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety, tolerability \& effectiveness of 2 strengths of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in the treatment of persistent asthma in adults \& adolescents.

Timeline

Start
2012-03
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Formoterol Other / unclassified 10 ug Inhaled
Comparator Mometasone Other / unclassified 200 ug Inhaled
Comparator Mometasone Other / unclassified 400 ug Inhaled

Indications